Dare Bioscience (DARE) Current Assets (2013 - 2026)
Dare Bioscience's (DARE) quarterly Current Assets came in at $27.1 million in Q4 2025, up 46.7% YoY from $18.4 million in Q4 2024, and up 8.24% on a QoQ basis from $25.0 million in Q3 2025.
Dare Bioscience (DARE) Current Assets (2013 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 13 years of Current Assets data on file, last reported at $27.1 million in Q4 2025.
- Quarterly Current Assets rose 46.7% year-over-year to $27.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27.1 million (up 46.7% YoY) and the FY2025 annual result came in at $27.1 million, up 46.7% from the prior year.
- Current Assets advanced to $27.1 million in Q4 2025, from $25.0 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $55.3 million in Q4 2021 to a low of $6.6 million in Q2 2025.
- A 5-year average of $27.2 million and a median of $22.3 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2021 — Current Assets soared 691.76% — and 2025, when it plunged 68.3%.
- Tracing DARE's Current Assets over 5 years: stood at $55.3 million in 2021, then fell by 22.17% to $43.0 million in 2022, then slumped by 59.24% to $17.5 million in 2023, then gained by 5.15% to $18.4 million in 2024, then surged by 46.7% to $27.1 million in 2025.
- The last three Current Assets figures came in at $27.1 million (Q4 2025), $25.0 million (Q3 2025), and $6.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - | 1.76 Bn |
| 10 | Dare Bioscience | 12.36 Mn | -257,544.46 | -132,343.00 | 16.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.69 Mn |
| Dec 31, 2025 | 27.06 Mn |
| Sep 30, 2025 | 25.00 Mn |
| Jun 30, 2025 | 6.60 Mn |
| Mar 31, 2025 | 11.82 Mn |
| Dec 31, 2024 | 18.45 Mn |
| Sep 30, 2024 | 14.95 Mn |
| Jun 30, 2024 | 20.83 Mn |
| Mar 31, 2024 | 9.98 Mn |
| Dec 31, 2023 | 17.54 Mn |
| Sep 30, 2023 | 22.44 Mn |
| Jun 30, 2023 | 22.24 Mn |
| Mar 31, 2023 | 29.51 Mn |
| Dec 31, 2022 | 43.04 Mn |
| Sep 30, 2022 | 49.57 Mn |
| Jun 30, 2022 | 50.11 Mn |
| Mar 31, 2022 | 47.82 Mn |
| Dec 31, 2021 | 55.30 Mn |
| Sep 30, 2021 | 48.24 Mn |
| Jun 30, 2021 | 14.06 Mn |